GXE:ETR
Lakefront Biotherapeutics NV
€26.40
arrow_downward
-1.93%(-0.52) 1D
Okt 16, 5:35:49 PM GMT+2 · EUR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa GXE...
Buksan
€26.76
Mataas
€26.76
Mababa
€26.28
Mkt. cap
1.79B
Avg. na dami
621.00
Dami
2.00
P/E ratio
2.92
Mataas nang 52-wk
€30.02
Mababa nang 52-wk
€22.84
EPS
€9.05
Bilang ng mga empleyado
196
Buksan
€26.76
Mataas
€26.76
Mababa
€26.28
Mkt. cap
1.79B
Avg. na dami
621.00
Dami
2.00
P/E ratio
2.92
Mataas nang 52-wk
€30.02
Mababa nang 52-wk
€22.84
EPS
€9.05
Bilang ng mga empleyado
196
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
BioSpace
·
2 araw ang nakalipas
Stoffels strikes up new biotech in return to Galapagos cell therapy mission
Profile
Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
Tungkol sa Lakefront Biotherapeutics NV
CEOPaul Stoffels | Paul Stoffels
Mga Empleyado196
Itinatag1999
Headquarters-
Sektor-
Websitelakefrontbio.com